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Abstract
C-mannosylation was recently identified in the thrombospondin-related anonymous protein
(TRAP) from Plasmodium falciparum salivary gland sporozoites. A candidate P. falciparum
C-mannosyltransferase (PfDPY-19) was demonstrated to modify thrombospondin type 1
repeat (TSR) domains in vitro, exhibiting a different acceptor specificity than their mamma-
lian counterparts. According to the described minimal acceptor of PfDPY19, several TSR
domain-containing proteins of P. falciparum could be C-mannosylated in vivo. However,
the relevance of this protein modification for the parasite viability remains unknown. In
the present study, we used CRISPR/Cas9 technology to generate a PfDPY19 null mutant,
demonstrating that this glycosyltransferase is not essential for the asexual blood development
of the parasite. PfDPY19 gene disruption was not associated with a growth phenotype, not
even under endoplasmic reticulum-stressing conditions that could impair protein folding.
The data presented in this work strongly suggest that PfDPY19 is unlikely to play a critical
role in the asexual blood stages of the parasite, at least under in vitro conditions.
Introduction
Malaria remains one of the most serious global infectious diseases. Only in 2017, it was
responsible for 219 million cases and 435 000 deaths worldwide (World Health
Organization, 2018). It is generally accepted that malaria elimination from the remaining
endemic countries will not be possible with currently available strategies (Alonso et al.,
2011). In this regard, a better understanding of the numerous gaps of knowledge in the com-
plex biology of the parasite would facilitate the rationale design of new interventions.
The thrombospondin type 1 repeat (TSR) superfamily is a diverse group of proteins often
involved in interactions with the extracellular matrix (Tucker, 2004; Morahan et al., 2009).
Particularly, the functional characterization of P. falciparum TSR domain-containing proteins
revealed the essential roles that these effectors play in processes involved in cell invasion, egres-
sion and transmission of the parasite through the mosquito stages. Thus, circumsporozoite-
and TRAP-related protein (CTRP) is essential for ookinete invasion of the mosquito midgut
epithelium and oocyst development (Dessens et al., 1999), whereas thrombospondin-related
protein 1 is required for the subsequent sporozoite egress from oocysts (Klug and
Frischknecht, 2017). TRAP, circumsporozoite protein (CSP) and TRAP-related protein are
all involved in the sporozoite invasion of the mosquito salivary glands; in the vertebrate
host, CSP and TRAP also bind to the hepatocyte surface during sporozoite invasion
(Ménard et al., 1997; Sultan et al., 1997; Combe et al., 2009). Finally, TRAP-like protein
and thrombospondin-related sporozoite protein have been described to play an important
role in hepatocyte cell traversal (Labaied et al., 2007; Moreira et al., 2008). Other TSR domain-
containing proteins are expressed in the blood stages of the parasite. Previously described to be
essential for the merozoite invasion of erythrocytes (Baum et al., 2006), more recent studies
revealed that the merozoite TRAP family protein (MTRAP) is completely dispensable for
the viability of asexual parasites. Instead, MTRAP was demonstrated to be essential for gam-
etocyte egress and, thus, for transmission to the mosquito (Bargieri et al., 2016). On the other
hand, the thrombospondin-related apical merozoite protein (TRAMP) seems to be involved in
the invasion of erythrocytes, since antibodies raised against this protein block merozoite inva-
sion (Siddiqui et al., 2013). Interestingly, a secreted protein with altered thrombospondin
repeat domain (SPATR) is expressed at multiple stages of the parasite such as sporozoites,
asexual blood stages and gametocytes. Antibodies raised against SPATR block hepatocyte inva-
sion by sporozoites; however, the biological relevance of SPATR during other stages of the
parasite has not been addressed (Chattopadhyay et al., 2003).
The elucidation of the crystal structure of TSR domains revealed an unusual three-stranded
fold known as the tryptophan ladder, also found in type 1 cytokine receptors and characterized
by a motif of stacked aromatic and basic amino acids stabilized by disulfide bonds (Tan et al.,
2002; Olsen and Kragelund, 2014). In other organisms, TSR domains can be modified by two
types of glycosylation, namely O-fucosylation and C-mannosylation. The protein
O-fucosyltransferase 2 (PoFUT2) catalyses the O-fucose modification of TSR domains,
which in turn may be elongated by a β3-glucosyltransferase (Kozma et al., 2006; Luo et al.,
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2006). On the other hand, DPY19 enzymes have been identified
as the glycosyltransferases responsible for TSR C-mannosylation
(Buettner et al., 2013; Shcherbakova et al., 2017). Recent works
revealed that TRAP and CSP are both modified in vivo by a deox-
yhexose and a hexose (presumably forming a glucose-β1,3-fucose
O-glycan) in P. falciparum and P. vivax salivary gland sporozoites.
Additionally, TRAP was also shown to be modified by an add-
itional hexose (presumably C-linked mannose) in P. falciparum
(Swearingen et al., 2016) but, interestingly, not in P. vivax
(Swearingen et al., 2017). These, and other works (Sanz et al.,
2013; Cova et al., 2015; Bandini et al., 2019), are renewing the
interest of the Plasmodium research community on the extent
and relevance of the parasite glycosylation.
PfPoFUT2 was demonstrated to be dispensable for the asexual
and sexual blood stage development of the parasite, in agreement
with the absence of predicted acceptors with the TSR
O-fucosylation consensus sequence (Lopaticki et al., 2017; Sanz
et al., 2019). On the contrary, the relevance of PfPoFUT2 for
the establishment of the infection in the mosquito host remains
a controversial issue. While Lopaticki et al. reported that
PfPoFUT2 gene disruption resulted in a deficient ookinete inva-
sion and a reduced sporozoite gliding motility and cell traversal
activity, Sanz et al. did not observe any evident phenotype second-
ary to PoFUT2 ablation, neither in P. falciparum nor in the mur-
ine model P. berghei. Interestingly, the phenotype described by
Lopaticki et al. was attributed to a deficient secretion of certain
PoFUT2 acceptors, in accordance with the proposed role of
O-fucosylation in a protein folding quality control system
(Vasudevan and Haltiwanger, 2014). However, to our knowledge,
the relevance of the C-mannosylation of P. falciparum
TSR-containing proteins has not been addressed before.
PfDPY19 was recently demonstrated to harbour a
C-mannosyltransferase activity in vitro (Hoppe et al., 2018).
Interestingly, PfDPY19 exhibited a different acceptor specificity
than the mammalian enzymes (see Table 1 for a list of putative
PfDPY19 acceptors). In other organisms, C-mannosylation has
been shown to be required for the efficient secretion of certain
acceptors, in accordance with the role played by this modifica-
tion in the stabilization of the tryptophan ladder (Buettner
et al., 2013; Shcherbakova et al., 2017). Taking into consider-
ation the proposed roles for some of the putative acceptors of
PfDPY19 in the asexual blood stages, we aimed to describe
the relevance of the gene for the viability of P. falciparum by dis-
rupting it and analysing the growth phenotype of ΔPfDPY19
mutant parasites.
Material and methods
Construction of plasmids for CRISPR/Cas9-mediated PfDPY19
knockout
A single guide RNA (sgRNA) targeting the PfDPY19 genomic
locus (PF3D7_0806200) was designed with the Eukaryotic
Pathogen gRNA Design Tool (Peng and Tarleton, 2015). To
generate the plasmid expressing the Streptococcus pyogenes Cas9
and the sgRNA, the primers 5′-TAAGTATATAATATTTAAAT-
TTAGGCCTTTCCATAGTTTTAGAGCTAGAA-3′ and 5′-TTC
TAGCTCTAAAACTATGGAAAGGCCTAAATTTAAATATTAT-
ATACTTA-3′ were annealed and ligated into a BbsI-digested
pDC2-Cas9-hDHFRyFCU plasmid (a generous gift from Ellen
Knuepfer) (Knuepfer et al., 2017). To generate the rescue
plasmid, two homology regions for PfDPY19 of ∼530 bp were
amplified from Pf3D7 1.2B genomic DNA with the primer pairs
5′-ATTCGAGCTCGGTACCCGGGAAATTATGTTGAGCAGA-
AACTTTCC-3′/5′CAGGTCGACTCTAGAGGATCCACGTCTC-
GAGCCCCAAGAATAATTTCTAAAAACAT-3′ and 5′-TTCTT
GGGGCTCGAGACGTGCGGCCGCATTATATGTTTTCAGCT-
TGTCTTCC-3′/5′-CAGGTCGACTCTAGAGGATCCGCAATA-
TGGAATATTACTTCCACAT-3′ and were cloned into a pUC19
backbone.
Table 1. Conservation of the apicomplexan DPY19 C-mannosyltransferase consensus sequence among TSR domain-containing proteins expressed in P. falciparum
Protein Gene ID W X X W X X C *
Sporozoite TRAP PF3D7_1335900 W D E W S P C Y
TLP PF3D7_0616500 W S E W S P C Y
TRSP PF3D7_0104000 W S E W S A C Y
TRP1 PF3D7_0822700 W S E W S T C Y
CSP PF3D7_0304600 S T E W S P C N
TREP PF3D7_1442600 W S E W S G P N
Ookinete CTRP PF3D7_0315200 W E E W S P C Y
F G E W S E C N
W S D W S S C Y
W E E W N E W N
W S D W S E C Y
W E T W V E C Y
W E E W G D C Y
Blood MTRAP PF3D7_1028700 W S E W S A C Y
W G E W S E C Y
SPATR PF3D7_0212600 W S D W S A C Y
PTRAMP PF3D7_1218000 W G E W S N C Y
CSP, circumsporozoite protein; CTRP, circumsporozoite and TRAP-related protein; MTRAP, merozoite TRAP-like protein; PTRAMP, Plasmodium thrombospondin-related apical merozoite protein;
SPATR, secreted protein with altered thrombospondin repeat; TLP, TRAP-like protein; TRAP, thrombospondin-related anonymous protein; TREP, TRAP-related protein; TRP1,
thrombospondin-related protein 1; TRSP, thrombospondin-related sporozoite protein. Residues of the apicomplexan C-mannosylation consensus sequence are marked in bold, when conserved.
*TSR domains with or without a conserved C-mannosylation consensus sequence are marked as Y and N, respectively.
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Parasite culture and transfection
Plasmodium falciparum 3D7 1.2B line (kindly provided by
Cortés) (Cortés, 2005) was used for transfection and parasite
maintenance. Pf3D7 1.2B was cultured with B+ human ery-
throcytes in Roswell Park Memorial Institute (RPMI) medium
supplemented with Albumax-II at 37 °C under an atmosphere
of 92% N2, 3% O2 and 5% CO2, following standard methods
(Trager and Jensen, 1976). For PfDPY19 gene disruption,
60 µg of pDC2-Cas9-sgRNA-hDHFRyFCU plasmids and
15 µg of ScaI-linearized pUC19-PfDPY19 plasmids (Fig. 1A)
were transfected into Percoll-purified segmented schizonts by
electroporation with the Amaxa 4D system, as previously
described (Moon et al., 2013). Drug selection (i.e. 10 nM
WR99210 from Jacobus Pharmaceuticals) was first applied
∼20 h post-transfection and maintained for 4 days with daily
media changes. The emergence of resistant parasites was
monitored by visualizing Giemsa-stained blood smears by
light microscopy. Viable parasites were screened by PCR for
PfDPY19 gene disruption and treated for 1 week with 1 µM
5-fluorocytosine for negative selection of parasites containing
the pDC2-Cas9-sgRNA-hDHFRyFCU plasmid, prior to sub-
cloning by limiting dilution.
In vitro growth assay of parasite asexual development
To assess the biological relevance of PfDPY19 for the asexual
blood stage development of the parasite, the growth of two inde-
pendent clones of PfDPY19 null mutants was compared with that
of the wild-type parental line in three biological replicates.
Cultures were synchronized at ring stages by sorbitol synchroniza-
tion and parasitaemias were determined by flow cytometry
(FACSCalibur, BD Biosciences, Franklin Lakes, NJ, USA) using
the Syto 11 dye to discriminate between infected and uninfected
erythrocytes, as described elsewhere (Urbán et al., 2011).
Cultures were adjusted to ∼1.5% parasitaemia and 1% haemato-
crit. After incubation for one complete intraerythrocytic cycle
Fig. 1. PfDPY19 gene disruption. (A) The pDC2-Cas9-sgRNA-hDHFRyFCU expresses the S. pyogenes Cas9 endonuclease, the sgRNA targeting the PfDPY19 genomic
locus and a fusion protein of the positive selectable marker human dihydrofolate reductase (hDHFR) and the negative selectable marker yeast cytosine deaminase/
uridyl phosphoribosyl transferase (yFCU). The rescue plasmid (pUC19-PfDPY19) contains two homology regions of approximately 530 bp corresponding to the 5′
and 3′ ends of the PfDPY19 gene (PF3D7_0806200). (B) Schematic representation of PfDPY19 wild-type (up) and modified loci (down). In total, 2365 bp of the
PfDPY19 coding region (which contain the locus targeted by the designed sgRNA) are excised after double homologous recombination with homology region 1
(HR1) and 2 (HR2) from the rescue plasmid. (C) Polymerase chain reaction (PCR) screening of PfDPY19 disruption of wild-type parasites (3D7 WT) and three different
ΔPfDPY19 clones obtained by limited dilution. A negative control reaction (NC) was performed in the absence of template DNA to discard unspecific amplifications.
(D) Predicted transmembrane helices (red boxes) of PfDPY19 protein with the TMHMM Server v. 2.0 software (Krogh et al., 2001). Loops predicted to localize in the
lumen of the ER and the cytoplasm are marked in pink and blue, respectively. The shaded area indicates the deleted gene fragment in ΔPfDPY19 mutants. Amino
acids predicted to bind to dolichol-phosphate mannose in C. elegans (Ce) DPY19 are marked in red and are conserved in the P. falciparum (Pf) homologue (Buettner
et al., 2013).
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(∼48 h), parasitaemias were determined again by flow cytometry.
Multiplication rates for each strain were calculated as the ratio
between the final and the initial parasitaemia.
Oxidative stress induction and parasite survival assay
To assess the ability of PfDPY19 null mutants to cope with the
endoplasmic reticulum (ER)-stressing conditions, parasite cul-
tures were subjected to different concentrations of dithiothreitol
(DTT) as an oxidative stress proxy. Cultures were treated with
DTT at a final concentration of 0.05 and 0.15 M or, alterna-
tively, with phosphate buffered saline (PBS) as a negative con-
trol. After ∼48 h of incubation, parasitaemia was determined
by flow cytometry as described previously. The survival rate
for each strain was expressed as the ratio between the parasit-
aemia of the cultures treated with DTT and the negative con-
trols incubated with PBS.
Results
PfDPY19 is not essential for the asexual blood development of
P. falciparum
To investigate the relevance of the PfDPY19 C-mannosyltransfer-
ase, we disrupted the gene coding for this glycosyltransferase
(Fig. 1). As demonstrated by PCR, PfDPY19 gene was truncated
in edited parasites. Remarkably, the deleted gene fragment (see
striped box in Fig. 1B) codes for eight out of the nine predicted
transmembrane domains of the native protein. Moreover, the
delated fragment also codes for the conserved amino acids that
have been predicted to bind to the dolichol-phosphate mannose
precursor (Buettner et al., 2013). Given the magnitude of the
gene deletion, it is highly unlikely that the generated PfDPY19
null mutants could yield a functional C-mannosyltransferase activ-
ity. Thus, the viability of these mutants strongly suggests that
PfDPY19 is not essential for the asexual blood stage development
of the parasite.
PfDPY19 gene disruption does not affect parasite growth
Plasmodium falciparum expresses three TSR domain-containing
proteins during the blood stage development of the parasite, all
of which contain at least one TSR domain that conserves the
apicomplexan C-mannosylation consensus sequence W-X-X-
W-X-X-C (see Table 1). Specifically, antibodies raised against
TRAMP block the erythrocyte invasion of P. falciparum
merozoites (Siddiqui et al., 2013). To assess if PfDPY19 gene dis-
ruption could have an impact on the secretion of TRAMP (or
other acceptors) and, consequently, on parasite growth, we com-
pared the multiplication rate of PfDPY19 null mutants with that
of the parental wild-type line (Fig. 2A). However, we did not
observe any difference across three biological replicates, suggest-
ing that PfDPY19 disruption does not affect the parasite’s asexual
blood stage in vitro growth rate.
During the intraerythrocytic development, the parasite is exposed
to oxidative stress due to the host immune responses and the pro-
ducts generated during haemoglobin degradation. Thus, the parasite
is especially vulnerable to redox imbalances that affect protein fold-
ing in the ER (Chaubey et al., 2014). Given the alleged role of
C-mannosylation in the stabilization of the tryptophan ladder of
TSR domains (Buettner et al., 2013; Shcherbakova et al., 2017), we
compared the survival rate of PfDPY19 null mutants with that of
the parental wild-type line when subjected to different concentra-
tions of DTT (Fig. 2B) to assess the impact of the absence of a
PfDPY19 C-mannosyltransferase activity when coping with such
conditions. However, no significant differences were observed at
any of the DTT concentrations tested.
Discussion
The recent functional characterization of P. falciparum PoFUT2
suggests a critical role of O-fucosylation during the infection of
the mosquito host (Lopaticki et al., 2017), although these results
could not be replicated in an independent study (Sanz et al.,
2019). According to the work conducted by Lopaticki et al.,
PoFUT2 disruption results in a deficient secretion of TRAP,
which probably affects the parasite ability to invade hepatocytes.
Moreover, it is likely that other acceptors are also affected by
the absence of O-fucosyltransferase activity, as evidenced by the
deficient invasion of the mosquito midgut epithelium. Although
TRAP has also been demonstrated to be C-mannosylated in saliv-
ary gland sporozoites (Swearingen et al., 2016), the relevance of
this modification remains unknown. The essential role of
C-mannosylation for protein secretion observed in other organ-
isms (Buettner et al., 2013; Shcherbakova et al., 2017) prompted
us to investigate the contribution of PfDPY19 to parasite survival
and infectivity.
Contrary to O-fucosylation (Lopaticki et al., 2017; Sanz et al.,
2019), C-mannosylation is also expected to occur during the
blood stages of the parasite, as supported by the conservation of
the apicomplexan consensus sequence (Hoppe et al., 2018) in
the TSR domain-containing proteins PTRAMP, MTRAP and
Fig. 2. PfDPY19 disruption does not alter parasite growth. (A) The growth rate of 3D7 1.2B wild-type (3D7 WT) parasites and PfDPY19 null mutants (ΔDPY19 7A and
9C clones) was monitored over a complete intraerythrocytic cycle. Values are the mean of three biological replicates and error bars represent the standard vari-
ation. (B) Growth inhibition of 3D7 1.2B wild-type (3D7 WT) parasites and PfDPY19 null mutants (ΔDPY19 5C and 7A clones) at two DTT concentrations (0.05 and
0.15 M). Values are the mean of three technical replicates and error bars represent the standard deviation.
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SPATR (Table 1). However, the successful generation of a parasite
line with a severely truncated PfDPY19 gene strongly suggests
that this modification is not essential for the asexual development
of the parasite. Furthermore, parasite growth was not affected in
ΔPfDPY19 mutants, suggesting that the gene is not relevant dur-
ing the asexual multiplication of the parasite, at least under the
tested conditions. This finding is in partial agreement with a pre-
vious high-throughput screening study that described the gene
coding for PfDPY19 as dispensable, but conferring significant fit-
ness to P. falciparum in the asexual blood stages (Zhang et al.,
2018). The discrepancy might arise from slight deviations asso-
ciated with the comparison of sequencing reads as a proxy for
competitive growth fitness in this particular gene or genomic
region. The contribution of PfDPY19 to the secretion of the puta-
tive acceptors expressed in the blood stages has not been directly
assessed. Nevertheless, if there is an effect on protein secretion
secondary to PfDPY19 gene disruption, it does not seem to affect
neither parasite growth nor the parasite’s ability to cope with
DTT-induced oxidative stress. Contrary to this, a recent work
reports that Toxoplasma gondii DPY19 may be important for
the growth fitness of T. gondii tachyzoites, a related apicomplexan
(Gas-Pascual et al., 2019).
The O-fucosylation dependence for protein secretion seems to
be variable among the different acceptors that are expressed in the
mosquito stages of P. falciparum (Lopaticki et al., 2017). These
findings are in agreement with similar observations made with
human TSR domain-containing proteins after the loss of the
enzyme responsible for O-fucose elongation with glucose
(Vasudevan et al., 2015). Similarly, C-mannosylation seems to
be required for the secretion of only a subset of its acceptors in
C. elegans (Buettner et al., 2013; Shcherbakova et al., 2017).
Thus, this modification may be more relevant in other stages of
the parasite, where other putative effectors have also been
described to play essential roles for parasite viability and infectiv-
ity. For instance, given MTRAP essentiality for gametocyte egress
(Bargieri et al., 2016), a reduced secretion of this protein may
result in a deficient transmission to the mosquito. Likewise, a
reduced secretion of CTRP or TRAP as it has been reported
after PfPoFUT2 gene disruption (Lopaticki et al., 2017) may
cause a deficient mosquito midgut colonization and hepatocyte
invasion, respectively. Furthermore, specific in vivo environmen-
tal conditions, such as temperature variations or other ER stress
inducers, might affect the secretion of different acceptors along
the parasite life cycle, including the asexual blood stages. Hence,
further studies are required to define the function of PfDPY19
C-mannosyltransferase in Plasmodium parasites.
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